Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
June 26, 2023
AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
Diwakar Suresh, Akshatha N Srinivas, Akila Prashant, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 1, 2013
Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway
Senthilkumar Rajagopal, Divya P Kumar, Sunila Mahavadi, et al.
Frontiers in Pharmacology
|
March 13, 2023
The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator
Varsha D Shiragannavar, Nirmala G Sannappa Gowda, Lakshana D Puttahanumantharayappa, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 13, 2026
Hepatic loss of AATF attenuates MASH by suppressing AKT-mTORC1 signaling and reprogramming lipid metabolism
Akshatha N Srinivas, Diwakar Suresh, Prajna Anirvan, et al.
The Journal of Biological Chemistry
|
January 14, 2016
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
Divya P Kumar, Amon Asgharpour, Faridoddin Mirshahi, et al.
Scientific Reports
|
April 9, 2025
Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems
Diwakar Suresh, Bharathwaaj Gunaseelan, Akshatha N Srinivas, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2020
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis
Bubu A Banini, Divya P Kumar, Sophie Cazanave, et al.
Hepatology (Baltimore, Md.)
|
October 31, 2017
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puneet Puri, Suthat Liangpunsakul, Jeffrey E Christensen, et al.
Scientific Reports
|
May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
Sophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
June 26, 2023
AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma
Diwakar Suresh, Akshatha N Srinivas, Akila Prashant, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 1, 2013
Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway
Senthilkumar Rajagopal, Divya P Kumar, Sunila Mahavadi, et al.
Frontiers in Pharmacology
|
March 13, 2023
The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator
Varsha D Shiragannavar, Nirmala G Sannappa Gowda, Lakshana D Puttahanumantharayappa, et al.
Molecular Medicine (Cambridge, Mass.)
|
January 13, 2026
Hepatic loss of AATF attenuates MASH by suppressing AKT-mTORC1 signaling and reprogramming lipid metabolism
Akshatha N Srinivas, Diwakar Suresh, Prajna Anirvan, et al.
The Journal of Biological Chemistry
|
January 14, 2016
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
Divya P Kumar, Amon Asgharpour, Faridoddin Mirshahi, et al.
Scientific Reports
|
April 9, 2025
Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems
Diwakar Suresh, Bharathwaaj Gunaseelan, Akshatha N Srinivas, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2020
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis
Bubu A Banini, Divya P Kumar, Sophie Cazanave, et al.
Hepatology (Baltimore, Md.)
|
October 31, 2017
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puneet Puri, Suthat Liangpunsakul, Jeffrey E Christensen, et al.
Scientific Reports
|
May 16, 2020
Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
Sophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
Page
of 5